<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CiteSpace &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/citespace/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 14 Oct 2026 22:08:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>CiteSpace &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Chinese Patent Medicines in Breast Cancer: Landmark 34-Year Study Maps Research Boom and Reveals a Widening Evidence Gap</title>
		<link>https://bioengineer.org/chinese-patent-medicines-in-breast-cancer-landmark-34-year-study-maps-research-boom-and-reveals-a-widening-evidence-gap/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 22:08:10 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Bibliometric analysis]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[Chemotherapy Side Effects]]></category>
		<category><![CDATA[Chinese patent medicines]]></category>
		<category><![CDATA[CiteSpace]]></category>
		<category><![CDATA[Clinical guidelines]]></category>
		<category><![CDATA[complementary therapy]]></category>
		<category><![CDATA[Evidence-based medicine]]></category>
		<category><![CDATA[herbal polysaccharides]]></category>
		<category><![CDATA[supportive cancer care]]></category>
		<category><![CDATA[traditional Chinese medicine]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=419551</guid>

					<description><![CDATA[A 34-year bibliometric analysis of 1,847 publications reveals booming research on Chinese patent medicines in breast cancer care, alongside a stark gap between clinical guidelines and product labeling.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">419551</post-id>	</item>
	</channel>
</rss>
